Noah Berkowitz - 13 Feb 2026 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role: Chief Medical Officer
Signature: /s/ Christina Bailey, as attorney-in-fact for Noah Berkowitz
Issuer symbol: ARVN
Transactions as of: 13 Feb 2026
Net transactions value: -$67,595
Form type: 4
Filing time: 18 Feb 2026, 18:12:15 UTC
Previous filing: 13 May 2025
Next filing: 02 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Berkowitz Noah	Chief Medical Officer	C/O ARVINAS, INC., 5 SCIENCE PARK, 395 WINCHESTER AVE., NEW HAVEN	/s/ Christina Bailey, as attorney-in-fact for Noah Berkowitz	18 Feb 2026	0001369900

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARVN	Common Stock	Sale	$67,595	-5,685	-3.4%	$11.89	163,938	13 Feb 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of 25% of the reporting person's restricted stock units (RSUs) granted on February 13, 2025. The sale does not represent a discretionary trade.